documents: FDA-2013-P-1641-0004
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-P-1641-0004 | FDA | FDA-2013-P-1641 | Presentation from TEVA Pharmacuetical re February 25, 2014 Type C FDA Meeting on Scientific Data on Copaxone’s Complexity and Mode of Action in Consideration of Evidentiary Standards for Follow on Products | Other | Presentation | 2014-03-05T05:00:00Z | 2014 | 3 | 2014-03-05T05:00:00Z | 2014-03-06T14:40:23Z | 0 | 0 | 09000064815fccf0 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref